HomeTOP STORIESGenentech multiple sclerosis candidate fenebrutinib meets goal in late-stage trial Genentech multiple sclerosis candidate fenebrutinib meets goal in late-stage trial By rogerjudd February 7, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleBlock may eliminate up to 10% of positions – reportNext articleTwo teens arrested after 15-year-old shot near Washington, DC’s Union Station latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
